Sutherland Healthcare Solutions

SutherlandHealthcare.com

Analytics-driven business process and technology solutions to optimize healthcare’s financial and clinical performance. We are a leading provider of consulting, process transformation services, information technology (IT) optimization, analytics, and design thinking solutions to the entire healthcare ecosystem. We have 5,000 dedicated employees in 15+ global sites delivering customized and scalable solutions, including: contact center, coding, revenue cycle management, healthcare IT, provider data management, experience consulting, and population and payment solutions.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research, PHARMA TECH

BIOCYTOGEN ANNOUNCES NON-EXCLUSIVE LICENSE AGREEMENT WITH JANSSEN BIOTECH

Biocytogen | March 09, 2023

news image

On March 8, 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The deal was facilitated by Johnson & Johnson Innovation LLC. Under the agreement, Janssen and its affiliates have been granted a global, non-exclusive license to utilize Biocytogen's RenLite® platform and its underlying intellectual propert...

Read More

Pharmacy Market

KONEKSA LAUNCHES ACADEMIC COLLABORATION PROGRAM FOR PARKINSON’S DISEASE

Businesswire | August 18, 2023

news image

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs. The first collaboration of the KAPP-PD program, with Oregon Health & Science University (OHSU), enables the inclusion of app-and actigraphy-based digital measures and electronic patient reported outcome (...

Read More

Pharmacy Market

M-PHARMA AND KYOWA KIRIN SIGN EXCLUSIVE LICENSE AGREEMENT FOR COMMERCIALIZATION OF ILOFOTASE ALFA IN JAPAN

AM-Pharma | September 08, 2021

news image

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, and Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, today announced that they have entered into an exclusive license agreement under which Kyowa Kirin gains the rights to develop and commercialize ilofotase alfa, AM-Pharma’s proprietary recombinant human alkaline phosphatase. ...

Read More

GLOBAL ASEPTIC PACKAGING FOR THE PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE OUTLOOK TO 2025

Fashion Trends Now | April 09, 2020

news image

The research report on “Global Aseptic Packaging for the Pharmaceutical Market” serves in-depth analysis on latest and upcoming market scenario of Aseptic Packaging for the Pharmaceutical in the appraisal period, 2020-2025. The report survey Aseptic Packaging for the Pharmaceutical market growth past, sales channel, players profiled in Aseptic Packaging for the Pharmaceutical industry, product type and application market share and Aseptic Packaging for the Pharmaceutical regional sco...

Read More
news image

Research, PHARMA TECH

BIOCYTOGEN ANNOUNCES NON-EXCLUSIVE LICENSE AGREEMENT WITH JANSSEN BIOTECH

Biocytogen | March 09, 2023

On March 8, 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The deal was facilitated by Johnson & Johnson Innovation LLC. Under the agreement, Janssen and its affiliates have been granted a global, non-exclusive license to utilize Biocytogen's RenLite® platform and its underlying intellectual propert...

Read More
news image

Pharmacy Market

KONEKSA LAUNCHES ACADEMIC COLLABORATION PROGRAM FOR PARKINSON’S DISEASE

Businesswire | August 18, 2023

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs. The first collaboration of the KAPP-PD program, with Oregon Health & Science University (OHSU), enables the inclusion of app-and actigraphy-based digital measures and electronic patient reported outcome (...

Read More
news image

Pharmacy Market

M-PHARMA AND KYOWA KIRIN SIGN EXCLUSIVE LICENSE AGREEMENT FOR COMMERCIALIZATION OF ILOFOTASE ALFA IN JAPAN

AM-Pharma | September 08, 2021

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, and Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life sciences and technologies, today announced that they have entered into an exclusive license agreement under which Kyowa Kirin gains the rights to develop and commercialize ilofotase alfa, AM-Pharma’s proprietary recombinant human alkaline phosphatase. ...

Read More
news image

GLOBAL ASEPTIC PACKAGING FOR THE PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE OUTLOOK TO 2025

Fashion Trends Now | April 09, 2020

The research report on “Global Aseptic Packaging for the Pharmaceutical Market” serves in-depth analysis on latest and upcoming market scenario of Aseptic Packaging for the Pharmaceutical in the appraisal period, 2020-2025. The report survey Aseptic Packaging for the Pharmaceutical market growth past, sales channel, players profiled in Aseptic Packaging for the Pharmaceutical industry, product type and application market share and Aseptic Packaging for the Pharmaceutical regional sco...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us